Alibaba
BABA
Apple
AAPL
Netflix
NFLX
Tesla
TSLA
Microsoft
MSFT
US Stock MarketDetailed Quotes
MGNX Macrogenics
- 1.480
- -0.080-5.13%
Close Mar 27 16:00 ET
- 1.500
- +0.020+1.35%
Post 20:01 ET
93.37MMarket Cap-1.38P/E (TTM)
1.541High1.460Low949.92KVolume1.530Open1.560Pre Close1.42MTurnover1.82%Turnover RatioLossP/E (Static)63.09MShares19.54152wk High0.80P/B77.46MFloat Cap1.46052wk Low--Dividend TTM52.34MShs Float41.000Historical High--Div YieldTTM5.17%Amplitude1.460Historical Low1.490Avg Price1Lot Size
About Macrogenics Company
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.
Company Profile
SymbolMGNX
Company NameMacrogenics
Listing DateOct 10, 2013
Issue Price16.00
Founded2000
CEODr. Scott Koenig, M.D.,PhD
MarketNASDAQ
Employees341
Fiscal Year Ends12-31
Address9704 Medical Center Drive
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850-3368
Phone1-301-251-5172
Websitehttp://www.macrogenics.com
Company Executives
- Name
- Position
- Salary
- Dr. Scott Koenig, M.D.,PhD
- Director, President and Chief Executive Officer
- 3.71M
- Eric Risser
- Chief Operating Officer
- --
- Dr. Stephen L. Eck
- Senior Vice President, Clinical Development and Chief Medical Officer
- 1.75M
- Dr. Ezio Bonvini, M.D.
- Senior Vice President, Research and Chief Scientific Officer
- --
- James Karrels
- Senior Vice President, Chief Financial Officer and Corporate Secretary
- 1.58M
- Jeffrey Stuart Peters
- Senior Vice President, General Counsel and Corporate Compliance Officer
- --
- Beth Smith
- Vice President, Controller, Treasurer and Principal Accounting Officer
- --
- Thomas Spitznagel
- Senior Vice President, Technical Operations
- --
- William K. Heiden
- Chairman of the Board
- 180.13K
- Meenu Chhabra Karson
- Independent Director
- 335.41K
- Federica O'Brien
- Independent Director
- 152.00K
- Scott T. Jackson, M.B.A.
- Independent Director
- 167.63K
- Edward M. Hurwitz, J.D.
- Independent Director
- 147.63K
- Dr. Margaret A. Liu, M.D.
- Independent Director
- 318.32K
- Dr. Karen Jean Ferrante, M.D.
- Independent Director
- 135.75K
- Dr. Jay Siegel, M.D.
- Independent Director
- 167.21K
- Dr. David C. Stump,M.D.
- Independent Director
- 160.75K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.